Gastric distension by ingesting food is useful in the evaluation of primary gastric cancer by FDG PET

Clinical Nuclear Medicine

Volumn 32, Issue 2, 2007, Pages 106-109

  Zhu, Zhaohui ^a   Li, Fang ^a   Zhuang, Hongming ^b  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

FDG PET; Gastric carcinoma; Gastric distention

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CASE REPORT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FOOD INTAKE; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; STOMACH CANCER; STOMACH DISTENSION; SURVIVAL RATE; WHOLE BODY IMAGING;

AGED; EATING; FASTING; FLUORODEOXYGLUCOSE F18; FOOD; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; STOMACH; STOMACH NEOPLASMS;

EID: 33846431967     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rlu.0000252181.76139.5e     Document Type: Article

References (20)

1. Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol. 2006;12:354-362.
2. Triantafillidis JK, Cheracakis P. Diagnostic evaluation of patients with early gastric cancer - a literature review. Hepatogastroenterology. 2004;51:618-624.
3. Catalano V, Labianca R, Beretta GD, et al. Gastric cancer. Crit Rev Oncol Hematol. 2005;54:209-241.
4. Jansen EP, Boot H, Verheij M, et al. Optimal locoregional treatment in gastric cancer. J Clin Oncol. 2005;23:4509-4517.
5. Chen J, Cheong JH, Yun MJ, et al. Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography. Cancer. 2005;103:2383-2390.
6. Mochiki E, Kuwano H, Katoh H, et al. Evaluation of 18F-2-deoxy-2-fluoro- D-glucose positron emission tomography for gastric cancer. World J Surg. 2004;28:247-253.
7. Ott K, Fink U, Becker K, et al. Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: results of a prospective trial. J Clin Oncol. 2003;21:4604-4610.
8. Jadvar H, Tatlidil R, Garcia AA, et al. Evaluation of recurrent gastric malignancy with F-18 -FDG positron emission tomography. Clin Radiol. 2003;58:215-221.
9. Kawamura T, Kusakabe T, Sugino T, et al. Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survival. Cancer. 2001;92:634-641.
10. Buyyounouski MK, Klump WJ, Konski A, et al. FDG PET imaging of signet-ring cell adenocarcinoma of the stomach. Clin Nucl Med. 2005;30:118-119.
11. Salaun PY, Grewal RK, Dodamane I, et al. An analysis of the 18F-FDG uptake pattern in the stomach. J Nucl Med. 2005;46:48-51.
12. de Groot M, Meeuwis APW, Kok PJM, et al. Influence of blood glucose level, age and fasting period on non-pathological FDG uptake in heart and gut. Eur J Nucl Med Mol Imaging. 2005;32:98-101.
13. Nunez RF, Yeung HW, Macapinlac H. Increased F-18 FDG uptake in the stomach. Clin Nucl Med. 1999;24:281-282.
14. Kato T, Komatsu Y, Tsukamoto E, et al. Intense F-18FDG accumulation in the stomach in a patient with Menetrier's disease. Clin Nucl Med. 2002;27:376-377.
15. Ak I, Gulbas Z. Intense F-18 FDG accumulation in stomach in a patient with Hodgkin lymphoma: Helicobacter pylori infection as a pitfall in oncologic diagnosis with F-18 FDG PET imaging. Clin Nucl Med. 2005;30:41-41.
16. Chamroonrat W, Zhuang H, Houseni M, et al. Malignant lesions can mimic gastric uptake on FDG PET. Clin Nucl Med. 2006;31:37-38.
17. Nakamoto Y, Tadamura E, Saga S, et al. An attempt to reduce physiological FDG accumulation in the heart and stomach using heparin [Abstract]. Eur J Nucl Med. 2001;28:PS25.
18. Yamamoto F, Nakada K, Zhao SJ, et al. Gastrointestinal uptake of FDG after N-butylscopolamine or omeprazole treatment in the rat. Ann Nucl Med. 2004;18:637-640.
19. Yun M, Choi HS, Yoo E, et al. The role of gastric distention in differentiating recurrent tumor from physiologic uptake in the remnant stomach on 18F-FDG PET. J Nucl Med. 2005;46:953-957.
20. Lehnert T, Rudek B, Buhl K, et al. Surgical therapy for loco-regional recurrence and distant metastasis of gastric cancer. Eur J Surg Oncol. 2002;28:455-461.